The markets are at a crossroads right now. It’s hard to know which way they’ll head. Corporate earnings suggest one thing; inflation suggests another. These three unusually active puts from Thursday...
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape Complements and transforms...
The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.81%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.20%. December E-mini...
The S&P 500 Index ($SPX ) (SPY ) today is up +1.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.81%. December E-mini S&P futures (ESZ25...
The S&P 500 Index ($SPX ) (SPY ) today is up +1.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.81%. December E-mini S&P futures (ESZ25...
December S&P 500 E-Mini futures (ESZ25) are up +0.92%, and December Nasdaq 100 E-Mini futures (NQZ25) are up +1.39% this morning as optimism that lawmakers are nearing a deal to end the longest government...
Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war against Novo Nordisk
NEW YORK , Nov. 7, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) today announced that it has entered into an amended merger agreement with Pfizer, pursuant to which Pfizer will acquire Metsera...
NEW YORK , Nov. 5, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) ("Metsera" or the "Company") today issued the following statement in response to a ruling in the litigation filed against the...
Stocks gained ground on Wall Street following several upbeat economic updates and a steady flow of quarterly reports from U.S. companies